The Accordion Pill Carbidopa/Levodopa (AP-CD/LD) administered three times a day reduced the variability of blood plasma levels of levodopa…
Articles by Patricia Inácio, PhD
Binding to, or chelating, toxic levels of iron in the brain can slow the progression of a neurodegenerative disorder known…
The formation of alpha-synuclein aggregates in brain nerve cells (neurons) is thought to be one of the hallmarks of Parkinson…
The U.S. Food and Drug Administration (FDA) has approved a generic equivalent to Sinemet (carbidopa/levodopa) for the…
Measuring the electric brain activity of people with Parkinson’s may be a non-invasive and accurate way of diagnosing the disease…
Mutations in the LRRK2 gene, which have been linked to familial Parkinson’s disease, impair the activity of the…
Mindfulness-based interventions can improve mental health status, including reduction of stress and anxiety levels, in family caregivers of veterans with…
A single-dose infusion of VY-AADC01, an investigational gene therapy, improves motor function and reduces the need for antiparkinsonian medications in…
Understanding and identifying epigenetic changes may become a potential strategy for early Parkinson’s diagnosis, when patients still lack the characteristic symptoms…
A pilot project in the United Kingdom is testing a wrist device that is worn like a watch, called Personal…